• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Amgen stock set for a decline

anonymous

Guest
Q3 2017 Amgen Earnings Conference Call
Wednesday, October 25, 2017 2:00 p.m. PT


  • When the street rips Amgens numbers
  • Repatha and Kyprolis not growing enough
  • Base business of Enbrel, Neulasta, etc declining
  • What will be the story behind why Amgen sucks by management?
 

<